Targeting TGF-β pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19
Trieu et al., medRxiv, doi:10.1101/2021.01.24.21250418
https://c19early.org/trieu.html